4//SEC Filing
Shea Jacqueline Elizabeth 4
Accession 0001055726-24-000024
CIK 0001055726other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:59 PM ET
Size
9.3 KB
Accession
0001055726-24-000024
Insider Transaction Report
Form 4
Shea Jacqueline Elizabeth
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-05-15−17,745→ 35,488 total→ Common Stock (17,745 underlying) - Tax Payment
Common Stock
2024-05-15$13.07/sh−7,718$100,874→ 33,647 total - Exercise/Conversion
Common Stock
2024-05-15+17,745→ 41,365 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares will vest on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
- [F3]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001771498
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:59 PM ET
- Size
- 9.3 KB